We are live on
!
Find out more
Westfield Capital Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
49.45%
This Fund
S&P 500
This Quarter
Est. Return
+7.07%
1 Year Est. Return
+49.45%
3 Year Est. Return
+148.08%
5 Year Est. Return
+180.9%
10 Year Est. Return
+972.69%
AUM
$17.4B
AUM Growth
+$359M
(+2.1%)
Cap. Flow
-$480M
Cap. Flow
% of AUM
-2.77%
Top 10 Holdings %
Top 10 Hldgs %
19.12%
Holding
357
New
45
Increased
93
Reduced
141
Closed
56
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$141M |
| 2 |
DFS
Discover Financial Services
DFS
|
+$129M |
| 3 |
Biogen
BIIB
|
+$126M |
| 4 |
United Therapeutics
UTHR
|
+$124M |
| 5 |
Whirlpool
WHR
|
+$106M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CBST
CUBIST PHARMACEUTICALS INC
CBST
|
+$274M |
| 2 |
ENDP
Endo International plc
ENDP
|
+$207M |
| 3 |
SHPG
Shire pic
SHPG
|
+$206M |
| 4 |
MWIV
MWI VETERINARY SUPPLY, INC.
MWIV
|
+$137M |
| 5 |
JPMorgan Chase
JPM
|
+$132M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.8% |
| 2 | Technology | 14.71% |
| 3 | Consumer Discretionary | 13.45% |
| 4 | Industrials | 12.27% |
| 5 | Communication Services | 9.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NORD
226
DELISTED
Nord Anglia Education, Inc.
NORD
| $13.1M | 0.08% |
578,029
-55,700
| -9% | -$1.15M |
|
|
KNL
227
DELISTED
Knoll, Inc.
KNL
| $12.7M | 0.07% |
+540,921
| New | +$11.2M |
|
|
DFRG
228
DELISTED
Del Frisco's Restaurant Group, Inc. Common Stock
DFRG
| $11.7M | 0.07% |
578,701
-177,229
| -23% | -$3.57M |
|
229
Malibu Boats
MBUU
$567M
| $11.1M | 0.06% |
475,845
-185
| -0% | -$3.85K |
|
230
iShares Russell 2000 Growth ETF
IWO
$15.1B
| $10.9M | 0.06% |
71,940
+62,540
| +665% | +$9.11M |
|
231
Gogo Inc
GOGO
$491M
| $10.8M | 0.06% |
+568,413
| New | +$9.68M |
|
232
Cadence Design Systems
CDNS
$93.4B
| $10.2M | 0.06% |
550,841
-208,045
| -27% | -$3.79M |
|
233
Tandem Diabetes Care
TNDM
$1.53B
| $9.76M | 0.06% |
77,356
+68,485
| +772% | +$8.91M |
|
|
CCXI
234
DELISTED
ChemoCentryx, Inc.
CCXI
| $9.6M | 0.06% |
1,272,098
-4,735
| -0.4% | -$37K |
|
235
Five Below
FIVE
$13.5B
| $9.53M | 0.05% |
267,910
-65,959
| -20% | -$2.2M |
|
236
Silicon Motion
SIMO
$8.68B
| $8.64M | 0.05% |
+321,493
| New | +$8.78M |
|
|
VA
237
DELISTED
Virgin America Inc.
VA
| $7.79M | 0.04% |
256,340
-24,150
| -9% | -$865K |
|
238
Bristol-Myers Squibb
BMY
$132B
| $5.7M | 0.03% |
88,330
+22,540
| +34% | +$1.41M |
|
239
Travel + Leisure Co
TNL
$4.7B
| $5.53M | 0.03% |
135,337
+28,707
| +27% | +$1.14M |
|
240
NXP Semiconductors
NXPI
$60.4B
| $5.34M | 0.03% |
53,180
-1,020,419
| -95% | -$89.9M |
|
241
Norfolk Southern
NSC
$75.1B
| $5.03M | 0.03% |
48,880
-210,013
| -81% | -$22.5M |
|
|
ZEN
242
DELISTED
ZENDESK INC
ZEN
| $5.02M | 0.03% |
+221,253
| New | +$5.3M |
|
243
Medtronic
MDT
$112B
| $4.99M | 0.03% |
63,960
+12,638
| +25% | +$958K |
|
244
Boeing
BA
$185B
| $4.93M | 0.03% |
32,830
| – | – |
|
245
IBM
IBM
$224B
| $4.82M | 0.03% |
31,425
+26,192
| +501% | +$3.97M |
|
246
GSK
GSK
$106B
| $4.76M | 0.03% |
82,496
+17,000
| +26% | +$975K |
|
247
Pfizer
PFE
$153B
| $4.67M | 0.03% |
141,505
+29,280
| +26% | +$931K |
|
|
SHPG
248
DELISTED
Shire pic
SHPG
| $4.37M | 0.03% |
18,265
-896,773
| -98% | -$206M |
|
249
Genuine Parts
GPC
$18.7B
| $4.16M | 0.02% |
44,680
+16,050
| +56% | +$1.55M |
|
|
TGNA
250
DELISTED
TEGNA Inc
TGNA
| $4.16M | 0.02% |
214,418
+46,163
| +27% | +$815K |
|
Similar funds
OAG
JG
CHP
SC
Westfield Capital Management's Q1 2015 Portfolio in Review
As of Q1 2015, Westfield Capital Management held 357 positions worth $17.4B, up 2.1% from $17B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Westfield Capital Management's Q1 2015 filing shows 45 new, 93 increased, 141 reduced and 56 closed positions. Its largest new stake was Mastercard: 1,619,899 shares worth $140M. The largest sale was CUBIST PHARMACEUTICALS INC, an estimated $274M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Discretionary.
- Westfield Capital Management's largest Q1 2015 buy was Mastercard: 1,619,899 shares worth $140M.
- Westfield Capital Management added most to Biogen in Q1 2015, an estimated $126M increase.
- Westfield Capital Management's biggest Q1 2015 reduction was Shire pic, cutting an estimated $206M.
- Westfield Capital Management fully exited CUBIST PHARMACEUTICALS INC in Q1 2015, selling an estimated $274M.
- Westfield Capital Management's ten largest holdings make up 19% of its $17.4B portfolio in Q1 2015.
- Westfield Capital Management opened 45 new positions and closed 56 in Q1 2015.
- Westfield Capital Management's portfolio value rose 2.1% quarter-over-quarter to $17.4B.
Based on Westfield Capital Management's 13F filing for Q1 2015, filed 13 May 2015.